INS and type 2 diabetes mellitus: In our study, we demonstrated that switching from premixed biphase insulin treatment to a combination of iDegLira for six months may improve glycemic control, reduce insulin requirements, and promote weight loss in patients with type 2 diabetes, while maintaining low glycemic variability.